FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹550 Cr | ₹615 Cr | ₹730 Cr | ₹690 Cr | ₹622 Cr |
What is the latest Total Current Liabilities ratio of FDC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹550 Cr |
| Mar2024 | ₹615 Cr |
| Mar2023 | ₹730 Cr |
| Mar2022 | ₹690 Cr |
| Mar2021 | ₹622 Cr |
How is Total Current Liabilities of FDC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹550 Cr | -10.54 | |
| Mar2024 | ₹615 Cr | -15.68 | |
| Mar2023 | ₹730 Cr | 5.67 | |
| Mar2022 | ₹690 Cr | 11.03 | |
| Mar2021 | ₹622 Cr | - | |
Compare Total Current Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,965.8 Cr | 3.8% | 9.8% | -16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 3.8% |
9.8% |
-16.2% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses